Peptide supplementation for improving nutritional status of cancer patients
- Conditions
- Cancer
- Registration Number
- PACTR202202585571226
- Lead Sponsor
- South China University of Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 80
Only those who will meet all of the following criteria will be eligible to be included in the study:
1. Histological confirmation of a newly diagnosed primary tumor
2. Patient BMI < 18 kg/m2;
3. Patients who received conventional radiotherapy or radiotherapy combined with chemotherapy after surgery;
4. Nutritional assessment results before chemotherapy showing malnutrition;
5. ECOG score 0-2;
6. Sign the informed consent voluntarily.
Those who meet any of the following criteria shall not be admitted to the study:
1. Frequent vomiting or conditions affecting oral administration (e.g., the patient has intestinal obstruction)
2. Pregnant or lactating women
3. Any other conditions that the investigator considers unsuitable for inclusion in the study, if the subject's compliance is known to be poor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method